How Postpartum Hemorrhage Medications Work

Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality worldwide. The primary goal of PPH treatment is to restore uterine tone, reduce bleeding, and maintain hemodynamic stability.

Treatment Options

• Oxytocin Administration (Gold Standard): Oxytocin is the first-line treatment for PPH due to its rapid onset of action and efficacy in stimulating uterine contractions. It works by binding to oxytocin receptors on the smooth muscle cells of the uterus, causing an increase in intracellular calcium levels and subsequent contraction.
• Alternatives:
  • Methylergonovine: A potent ergot alkaloid that stimulates uterine contractions by releasing serotonin and oxytocin. It is often used when oxytocin is ineffective or contraindicated.
  • Misoprostol: A synthetic prostaglandin E1 analogue that induces uterine contractions by stimulating the release of endogenous prostaglandins. It is commonly used in settings where oxytocin is not available or when there is a need for rapid treatment initiation.
  • Carbetocin: A long-acting oxytocin analogue that provides sustained uterine contraction and has a lower incidence of side effects compared to oxytocin.

Monitoring and Management

Effective management of PPH requires close monitoring of vital signs, bleeding, and uterine tone. Diagnostic tests such as Complete Blood Count (CBC), Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT), and Transvaginal Ultrasound may be ordered to assess the severity of PPH and guide treatment decisions.